Photobiomodulation therapy inhibits oral submucous fibrosis in mice

OBJECTIVES: Oral submucous fibrosis (OSMF) is a chronic inflammatory disease and a potentially malignant oral disorder. However, the best therapeutic treatment for OSMF remains uncertain. Our previous study showed that photobiomodulation (PBM) therapy and forskolin could reduce arecoline‐induced fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Min‐Hsuan, Lee, Kun‐Tsung, Chen, Chia‐Hsin, Chen, Ker‐Kong, Wang, Yan‐Hsiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Oral Mucosa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540580/
https://www.ncbi.nlm.nih.gov/pubmed/32391600
http://dx.doi.org/10.1111/odi.13409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540580/
https://www.ncbi.nlm.nih.gov/pubmed/32391600
http://dx.doi.org/10.1111/odi.13409

Ejemplares similares